Adalimumab adaz price?

Abrilada (adalimumab-adaz) is a biosimilar to Humira (adalimumab). Prices for adalimumab biosimilars vary a lot by country, dosage, and payer.

- In the United States, list prices for adalimumab biosimilars generally run in the several-thousand-dollar-per-month range before insurance. The exact monthly out-of-pocket depends on your dosage, plan, copays, and any manufacturer coupons or patient-assistance programs. Biosimilars are typically offered at discounts compared with Humira, but the savings can vary.

If you want a more precise figure, tell me:
- Your country or region
- Your prescribed regimen (monthly dose and how many syringes per month)
- Whether you want the list price or your out-of-pocket estimate (with insurance)

I can help you estimate or point you to current price sources (pharmacy websites, GoodRx, or the manufacturer’s patient-assistance programs).